Logo

Catherine Dumur

Nov 10, 2016

Aurora Diagnostics has named Catherine Dumur as director of molecular and next-generation sequencing development. Aurora, which is headquartered in Palm Beach Gardens, Florida, focuses on anatomic pathology and cancer diagnostics. Previously, Dumur served as the associate director of molecular diagnostics in the pathology department at Virginia Commonwealth University. She will be responsible for development and ongoing performance of NGS molecular diagnostic assays, proficiency testing, quality control, quality improvement programs, and signing out clinical cases.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.